No link to cardiac valvulopathy was seen in cabergoline treated patients

No link to cardiac valvulopathy was seen in cabergoline treated patients

<p><strong>Objective:</strong> To evaluate the association between use of cabergoline in patients with prolactinoma and risk of developing clinically relevant cardiac valvular disease.</p> <p><strong>Method:</strong> This was a descriptive cross sectional st...

Celý popis

Podrobná bibliografie
Hlavní autoři: K Dharshini, Noel Somasundaram, HMDPK Senevirathna, S Raj Kumar
Médium: Článek
Jazyk:English
Vydáno: Sri Lanka College of Endocrinologists 2012-10-01
Edice:Sri Lanka Journal of Diabetes Endocrinology and Metabolism
Témata:
prolactinoma
cabergoline
valvulopathy
On-line přístup:https://sjdem.sljol.info/articles/4775

Internet

https://sjdem.sljol.info/articles/4775

Podobné jednotky